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Improvements in genetic and genomic technology have enabled field-deployable molecular laboratories and
these have been deployed in a variety of epidemics that capture headlines. In this editorial, we highlight the
importance of building physical and personnel capacity in low and middle income countries to deploy these
technologies to improve diagnostics, understand transmission dynamics and provide feedback to endemic com-
munities on actionable timelines. We describe our experiences with molecular field research on schistosomiasis,
trypanosomiasis and rabies and urge the wider tropical medicine community to embrace these methods and
help build capacity to benefit communities affected by endemic infectious diseases.
Ebola, yellow fever, Zika and COVID-19 outbreaks in the last few
years have benefitted from real-time sequencing of pathogens
to understand the transmission and evolution of these emerging
viruses.1 The portability and low cost of MinION sequencers have
captured the imagination of researchers and the public, but also
made ‘lab in a suitcase’ sequencing a possibility. Studying genet-
ics no longer requires a laboratory facility with bright lights and
hefty equipment: the technology and creative solutions facilitat-
ing PCR product-free and sterile environments nearly anywhere
have enabled a rapid response to emerging pathogens. Although
these epidemics dominate headlines, we argue that these oppor-
tunities should also be extended to improve diagnostics, under-
standing of transmission dynamics and to design more effective
intervention strategies to target endemic infectious pathogens
in low and middle income countries (LMICs). Moreover, build-
ing core capacity and routine molecular surveillance in the areas
most burdened by infectious disease is critical to ensure epidemic
preparedness.
There is immense potential to use new technologies and low-
ered equipment costs to move capacity into those regions that
are most impacted by infectious diseases. Countless molecular
work currently relies on shipping samples to complete process-
ing, often with long delays and removed from those who collect
samples and deal with pathogens on a daily basis. The declining
cost of portable PCR machines, quantitative PCR and sequencers
make them a more feasible option and several are robust to
field conditions. These portable pieces of equipment mean that
machines can stay in country and be moved on site to study
specific endemic diseases in real time. They can even be used
in stationary laboratories to build scalable molecular capacity at
reference laboratories. Consumables are a real challenge, as we
discuss below, but newprotocols, tools and reagents are lowering
hurdles for conducting molecular work.
A key bottleneck to developing molecular capacity in the field,
or in areas with intermittent supply, is access to reliable electric-
ity. Power is required to run machines, heat samples during lysis
and to maintain a cold chain for essential reagents and unsta-
ble nucleic acids. Several creative solutions have removed the
need for electricity, ranging from hand-powered centrifuges to
temperature-stable polymerases. A range of commercially avail-
able reagents now no longer need refrigeration, require a ‘hot-
start’ to enable PCR set-up at room temperature, or both. These
advances reduce cross-amplification and enable accuratemolec-
ular work to be carried out in the field. In our work diagnosing
zoonotic human African trypanosomiasis (rHAT; causative agent
Trypanosoma brucei rhodesiense), we found that results obtained
in the field with a modified extraction protocol and temperature-
stable reagents were consistent with results later obtained with
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Figure 1. Field deployment of molecular laboratories in Uganda and Tanzania (A) for diagnosing Trypanosoma brucei rhodesiense (a causative agent
of human African trypanosomiasis), (B) zoonotic schistosomes and (C) rabies genomic surveillance.
the same samples in a molecular lab at Makerere University
(Figure 1A). If cold chains are necessary, liquid nitrogen, dry ice
and reusable ice packs can work for short-term options (days
to weeks). When we could not avoid power altogether, we used
solar panels and lithium batteries to run low wattage centrifuges
and PCR machines. Combining resources with the Coordinating
Office for the Control of Trypanosomiasis in Uganda and the Vec-
tor Control Division, Ministry of Health, Uganda, allowed purchase
of the equipment and enabled a field-deployable molecular lab.
The constraints of nucleic acid extraction can also be a major
hindrance to molecular work. New methods allow DNA extrac-
tion from plants, animals and environmental samples at room
temperature, or nearly room temperature. We have been using
FTATM cards to lyse cells, inactivate pathogens and bind DNA to
the matrix in field conditions. After 1 h of drying, DNA can be
eluted from tissue samples and whole organisms (i.e. parasites)
using modified solutions then used directly in PCR reactions
(Figure 1B). Expensive commercially available kits can rapidly
extract DNA within minutes in the field and possess single-use
contained columns to prevent cross-contamination. If more
extensive lysis steps are required before sample extraction, there
are portable tissue homogenisers and water baths that can be
powered by low wattage. In a pinch, toothpicks, thermometers,
candles and charcoal stoves have all been used successfully as
substitutes.
An additional challenge of conducting molecular work in the
field is maintaining a safe working space. The ARTIC network
(https://artic.network/ebov) has developed accessible protocols
to inactivate, amplify and sequence viral samples in the field
in a robust, sensitive and safe manner. The development of
portable laboratories has inspired many of the kit and processing
pipelines described here. These researchers have used portable
glove boxes to help contain infectious material before they are
inactivated, andmade their packing lists and operating protocols
open for others to learn from. Portable glove boxes help main-
tain safety, keep the space sterile, and can be lightweight and
packable (Figure 1C). PortableUV lights and bleach are both cheap
and effective in sterilising and preventing cross-contamination of
workspaces. However, the scope of work will be constrained by
the level of containment required for specific pathogens.
Field laboratories are increasingly being used for in-depth
studies that go beyond diagnosis, even generating whole
genomes. Our published and validated pipeline for rabies
genomic research can be applied in low-resource settings and
will be an important resource for informing elimination cam-
paigns.2 The Cassava Virus Action Project has developed genomic
pipelines to improve food security in Africa, using whole genome
sequencing to characterise the diversity of cassava viruses infect-
ing a farmer’s field and provide recommendations of which
strains of cassava would be ideal for replanting.3 This provides
increases in yield for the individual farmer but also provides
important information on how these cassava viruses are evolv-
ing in response to human control interventions.
The application of these new technologies must also be met
with a commitment to training local researchers. Funding for
some of our training work has come through the Global Chal-
lenges Research Fund, part of theUK’s Official Development Assis-
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and training opportunities are crucial for developing capacity and
we hope that such important financial support will continue. In
general, LMICs suffer from a lack of bioinformatic expertise, but
dedicated new initiatives such as the Pan African Bioinformatics
Network show promising growth in this area.4
One of the most beneficial aspects of field laboratories is the
speed at which samples can be collected and analysed. These
fast pipelines are revolutionising how we study outbreaks and
control important animal, plant and human diseases. Deployable
rabies virus sequencing has lowered costs and reduced sample-
to-sequence lag times from up to 6months (with sample export)
to a matter of days, providing rapid, actionable epidemiological
insights for rabies control efforts.2 The nearly instantaneous feed-
back to affected communities can help avoid fatigue that com-
munities experience when they must wait months or even years
for results. Whole genome sequencing of bacteria in the Philip-
pines is informing antimicrobial resistancemanagement and pol-
icy in real time.5 Field molecular laboratories can help identify
infected animals using pen-side tests and make informed deci-
sions on culling and treatment to limit future human cases and
economic losses.6
Despite these obvious benefits, we believe one of the biggest
challenges in conducting molecular work is sourcing and pay-
ing for consumables. Local suppliers in LMICs offer a limited
range of molecular reagents, items are often out of stock or take
months to deliver and are prohibitively expensive. Importation
regulations exacerbate the delays and expense of acquiring nec-
essary reagents, and customs delays compromise the integrity
of reagents. In our experience, airway bills, including duty tax
and in-transit cold storage costs, often exceed the price of the
reagents themselves. A secure, affordable supply chain will ulti-
mately ensure the sustainability of molecular research in LMICs.
While global companies continue to monopolise prices this will
remain a major challenge to research implementation in these
areas. Companies simply must do more to improve supply chains
and the accessibility of their products. The wider research com-
munity is also beginning to develop low-cost ‘do-it-yourself’ alter-
natives for some reagents, which provide alternatives to some of
these consumable needs (i.e. https://bomb.bio/about/).
By bringing the lab to the sample, it is possible to avoid delays
caused by shipping samples and long lag times in communicat-
ing results back to the affected communities. It is essential to
build physical and human capital to carry out this work within
endemic settings and ensure that consumables are not a limit-
ing factor in conducting this work. Helicopter science limits the
perspective of an endemic disease, and building confidence in the
application ofmolecularmethods throughout academic and gov-
ernment human and animal health institutions will only benefit
from these advances.
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